Director of Business Development, US
Science-backed nutraceutical company
Location: United States (East Coast preferred)
Reporting to: CEO
Commitment: Full-time
Compensation: $150,000-$175,000, High-performance bonus opportunity of up to 100% of base salary
GLP-1 therapies are rapidly transforming the treatment of obesity and metabolic disease. As adoption scales across telehealth platforms, obesity medicine clinics and digital health programs, a new challenge is emerging:
What happens after treatment ends?
The transition phase following GLP-1 discontinuation is increasingly recognised as a critical stage in long-term weight management. Patients often experience weight rebound, driven by fat mass regain, increased appetite signalling, and deterioration in metabolic markers. Despite the scale of GLP-1 adoption, this phase remains largely unaddressed.
This gap is creating a new category opportunity centred on post-GLP-1 metabolic transition support and weight-loss durability.
About the company
Our client has a well-established branded-Ingredient, backed by multiple clinical studies that is currently used by customers globally. They have recently conducted controlled clinical studies that have proven that this ingredient can support metabolic and appetite regulation during the withdrawal phase of GLP-1 therapy.
About the Business Development Director opportunity
To design and execute the US post-GLP-1 commercial strategy, translate clinical evidence into a differentiated market position, and build sustainable revenue through strategic partnerships.
This is a “builder role” effectively a business within a business.You will own the strategy from inception to execution. You will be operating without a pre-existing team or playbook and be expected to build momentum independently in a new market category. You will be able to collaborate with the wider organizations internal marketing, R&D, regulatory and leadership teams.
Key Responsibilities:
- Define and execute the US go-to-market strategy, identify and prioritise GLP-1 pathway partners, build a structured target account plan and negotiate / secure commercial partnerships outside of existing and traditional customer base
- Develop a new commercial model beyond traditional supplement channels by engaging telehealth platforms, obesity clinics, digital health companies, and practitioner networks
- Build relationships with decision makers and Key Opinion Leaders (KOLs)
- Deliver revenue from differentiated applications, drive adoption within post-GLP-1 care pathways, whilst maintaining clear separation from legacy ingredient supply
- Work closely with internal scientific, regulatory, and R&D teams, translate clinical data into compelling commercial narratives and support market education around post-GLP-1 outcomes
- Build awareness in emerging channels, support marketing and commercial initiatives and help define category language and positioning
Ideal Background:
- Experience in nutraceuticals, ingredients, or adjacent health sectors
- Preference for familiarity partnering with telehealth platforms, obesity clinics, digital health companies, and practitioner networks
- Track record of building new markets or business lines
- Experience in entrepreneurial or high-growth environments
Skills & Experience:
- Strong commercial execution capability
- Ability to operate in unstructured, early-stage environments
- Scientific literacy and ability to communicate clinical data
- Experience engaging senior stakeholders and decision makers
- Self-starter with strong ownership mindset
- Resilient and comfortable with ambiguity
- Clear, credible, and engaging communicator
- Commercially driven without being overly “sales-led”
